Fundraising FoxeGenesis, Inc. Full-time
operating company · company profileNew York · 2 people tracked
Find your way into eGenesis, Inc. Full-time
Sign up to see every warm intro you have to eGenesis, Inc. Full-time
- Paths you didn't know you had: your email and LinkedIn already hold routes to the eGenesis, Inc. Full-time team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
eGenesis addresses organ transplant scarcity through cross-species transplantation enabled by advanced genome engineering. The firm has built a porcine platform with targeted genetic edits to mitigate retroviral risk and achieve immunologic and molecular compatibility with human recipients, aiming to eliminate transplant waitlists and reduce mortality.
Source: firm website, verified Aug 6, 2026.
Team · 2 people
from the firm's website & public directories
President and Chief Executive Officer of eGenesis, leading the biotechnology company's genome engineering platform for xenotransplantation.
Paul J. Sekhri is Chairman, President, and Chief Executive Officer of vTv Therapeutics, where he has overseen the company's restructuring and financing to advance a diabetes therapy into Phase III clinical trials. With nearly four decades of experience in pharmaceutical and biotechnology leadership, he has served as Director, Chairman, or Executive Chairman on more than 40 public and private company boards across the United States, Europe, and Israel, with expertise in board governance, capital formation, M&A, and business development. He holds degrees in Membrane Physiology and Zoology from the University of Maryland School of Medicine and is based across North America and Europe.
Frequently asked questions
- What sectors does eGenesis, Inc. Full-time focus on?
- eGenesis, Inc. Full-time focuses on Biotech, Deep Tech, Medical Devices.
- Where is eGenesis, Inc. Full-time located?
- eGenesis, Inc. Full-time is headquartered in New York, US.
Images
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Blackbird is a venture capital firm that backs founders from the earliest stages, with a focus on ambitious technology startups across Australia and New Zealand.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.